Financhill
Sell
48

FCX Quote, Financials, Valuation and Earnings

Last price:
$40.26
Seasonality move :
6.07%
Day range:
$39.21 - $40.37
52-week range:
$33.98 - $55.24
Dividend yield:
1.49%
P/E ratio:
31.20x
P/S ratio:
2.28x
P/B ratio:
3.29x
Volume:
21.6M
Avg. volume:
16.6M
1-year change:
-12.95%
Market cap:
$57.8B
Revenue:
$25.5B
EPS (TTM):
$1.29
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $14.2B $22.8B $22.8B $22.9B $25.5B
Revenue Growth (YoY) -1.42% 60.9% -0.29% 0.33% 11.38%
 
Cost of Revenues $11.7B $14B $15.1B $15.7B $17.8B
Gross Profit $2.5B $8.8B $7.7B $7.2B $7.7B
Gross Profit Margin 17.91% 38.59% 33.76% 31.33% 30.09%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $370M $383M $420M $479M $513M
Other Inc / (Exp) $431M -$25M $240M $296M $362M
Operating Expenses $579M $529M $656M $935M $796M
Operating Income $2B $8.3B $7B $6.2B $6.9B
 
Net Interest Expenses $598M $602M $560M $515M $319M
EBT. Incl. Unusual Items $1.8B $7.7B $6.7B $6B $6.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $944M $2.3B $2.3B $2.3B $2.5B
Net Income to Company $865M $5.4B $4.5B $3.8B $4.4B
 
Minority Interest in Earnings -$266M -$1.1B -$1B -$1.9B -$2.5B
Net Income to Common Excl Extra Items $599M $4.3B $3.5B $1.8B $1.9B
 
Basic EPS (Cont. Ops) $0.41 $2.93 $2.40 $1.28 $1.31
Diluted EPS (Cont. Ops) $0.41 $2.90 $2.39 $1.28 $1.30
Weighted Average Basic Share $1.5B $1.5B $1.4B $1.4B $1.4B
Weighted Average Diluted Share $1.5B $1.5B $1.5B $1.4B $1.4B
 
EBITDA $3.9B $10.3B $9.3B $8.6B $9.5B
EBIT $2.4B $8.3B $7.3B $6.5B $7.2B
 
Revenue (Reported) $14.2B $22.8B $22.8B $22.9B $25.5B
Operating Income (Reported) $2B $8.3B $7B $6.2B $6.9B
Operating Income (Adjusted) $2.4B $8.3B $7.3B $6.5B $7.2B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $4.5B $6.2B $5.8B $5.9B $5.7B
Revenue Growth (YoY) 14.93% 37.13% -6.59% 2.55% -3.13%
 
Cost of Revenues $3.1B $3.7B $4B $3.9B $4.3B
Gross Profit $1.4B $2.4B $1.7B $2B $1.4B
Gross Profit Margin 31.79% 39.6% 30.12% 33.13% 24.91%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $97M $94M $107M $120M $129M
Other Inc / (Exp) $482M -$144M $143M $103M $67M
Operating Expenses $206M $153M $205M $234M $182M
Operating Income $1.2B $2.3B $1.5B $1.7B $1.2B
 
Net Interest Expenses $236M $171M $137M $97M $70M
EBT. Incl. Unusual Items $1.5B $2B $1.5B $1.7B $1.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $611M $625M $557M $724M $520M
Net Income to Company $858M $1.4B $977M $1B $721M
 
Minority Interest in Earnings -$150M -$252M -$280M -$619M -$447M
Net Income to Common Excl Extra Items $708M $1.1B $697M $388M $274M
 
Basic EPS (Cont. Ops) $0.49 $0.76 $0.49 $0.27 $0.19
Diluted EPS (Cont. Ops) $0.48 $0.74 $0.48 $0.27 $0.19
Weighted Average Basic Share $1.5B $1.5B $1.4B $1.4B $1.4B
Weighted Average Diluted Share $1.5B $1.5B $1.4B $1.4B $1.4B
 
EBITDA $2.1B $2.7B $2.2B $2.4B $1.8B
EBIT $1.7B $2.1B $1.7B $1.8B $1.3B
 
Revenue (Reported) $4.5B $6.2B $5.8B $5.9B $5.7B
Operating Income (Reported) $1.2B $2.3B $1.5B $1.7B $1.2B
Operating Income (Adjusted) $1.7B $2.1B $1.7B $1.8B $1.3B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $14.2B $22.8B $22.8B $22.9B $25.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $11.7B $14B $15.1B $15.7B $17.8B
Gross Profit $2.5B $8.8B $7.7B $7.2B $7.7B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $370M $383M $420M $479M $513M
Other Inc / (Exp) $431M -$25M $240M $296M $362M
Operating Expenses $579M $529M $656M $935M $796M
Operating Income $2B $8.3B $7B $6.2B $6.9B
 
Net Interest Expenses $598M $602M $560M $515M $319M
EBT. Incl. Unusual Items $1.8B $7.7B $6.7B $6B $6.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $944M $2.3B $2.3B $2.3B $2.5B
Net Income to Company $865M $5.4B $4.5B $3.8B $4.4B
 
Minority Interest in Earnings -$266M -$1.1B -$1B -$1.9B -$2.5B
Net Income to Common Excl Extra Items $599M $4.3B $3.5B $1.8B $1.9B
 
Basic EPS (Cont. Ops) $0.40 $2.94 $2.40 $1.28 $1.30
Diluted EPS (Cont. Ops) $0.39 $2.89 $2.37 $1.27 $1.29
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $3.9B $10.3B $9.3B $8.6B $9.5B
EBIT $2.4B $8.3B $7.3B $6.5B $7.2B
 
Revenue (Reported) $14.2B $22.8B $22.8B $22.9B $25.5B
Operating Income (Reported) $2B $8.3B $7B $6.2B $6.9B
Operating Income (Adjusted) $2.4B $8.3B $7.3B $6.5B $7.2B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $22.8B $22.8B $22.9B $25.5B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $14B $15.1B $15.7B $17.8B --
Gross Profit $8.8B $7.7B $7.2B $7.7B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $383M $420M $479M $513M --
Other Inc / (Exp) -$25M $240M $296M $362M --
Operating Expenses $529M $656M $935M $796M --
Operating Income $8.3B $7B $6.2B $6.9B --
 
Net Interest Expenses $602M $560M $515M $319M --
EBT. Incl. Unusual Items $7.7B $6.7B $6B $6.9B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.3B $2.3B $2.3B $2.5B --
Net Income to Company $5.4B $4.5B $3.8B $4.4B --
 
Minority Interest in Earnings -$1.1B -$1B -$1.9B -$2.5B --
Net Income to Common Excl Extra Items $4.3B $3.5B $1.8B $1.9B --
 
Basic EPS (Cont. Ops) $2.94 $2.40 $1.28 $1.30 --
Diluted EPS (Cont. Ops) $2.89 $2.37 $1.27 $1.29 --
Weighted Average Basic Share $5.9B $5.8B $5.7B $5.8B --
Weighted Average Diluted Share $5.9B $5.8B $5.8B $5.8B --
 
EBITDA $10.3B $9.3B $8.6B $9.5B --
EBIT $8.3B $7.3B $6.5B $7.2B --
 
Revenue (Reported) $22.8B $22.8B $22.9B $25.5B --
Operating Income (Reported) $8.3B $7B $6.2B $6.9B --
Operating Income (Adjusted) $8.3B $7.3B $6.5B $7.2B --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $3.7B $8.1B $8.1B $4.8B $3.9B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $892M $1.2B $1.3B $1.2B $578M
Inventory $3.9B $4.5B $5.2B $6.1B $6.8B
Prepaid Expenses -- -- -- -- --
Other Current Assets $341M $523M $381M $375M $535M
Total Current Assets $9.3B $14.8B $15.6B $14.1B $13.3B
 
Property Plant And Equipment $29.8B $30.3B $32.6B $35.3B $38.5B
Long-Term Investments $295M $232M $262M $207M $456M
Goodwill -- -- -- -- --
Other Intangibles $401M $412M $416M $422M $428M
Other Long-Term Assets $1.9B $1.8B $1.6B $1.9B $1.8B
Total Assets $42.1B $48B $51.1B $52.5B $54.8B
 
Accounts Payable $1.5B $2B $2.7B $2.5B $2.8B
Accrued Expenses $837M $857M $866M $540M $530M
Current Portion Of Long-Term Debt $34M $372M $1B $766M $41M
Current Portion Of Capital Lease Obligations $38M $38M $38M $84M $98M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $3.4B $5.9B $6.3B $5.8B $5.5B
 
Long-Term Debt $9.7B $9.1B $9.6B $8.7B $8.9B
Capital Leases -- -- -- -- --
Total Liabilities $23.5B $25B $26.2B $25.2B $26.1B
 
Common Stock $159M $160M $161M $162M $162M
Other Common Equity Adj -$583M -$388M -$320M -$274M -$314M
Common Equity $10.2B $14B $15.6B $16.7B $17.6B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $8.5B $9B $9.3B $10.6B $11.2B
Total Equity $18.7B $23B $24.9B $27.3B $28.8B
 
Total Liabilities and Equity $42.1B $48B $51.1B $52.5B $54.8B
Cash and Short Terms $3.7B $8.1B $8.1B $4.8B $3.9B
Total Debt $9.7B $9.5B $10.6B $9.4B $8.9B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $3.7B $8.1B $8.1B $4.8B $3.9B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $892M $1.2B $1.3B $1.2B $578M
Inventory $3.9B $4.5B $5.2B $6.1B $6.8B
Prepaid Expenses -- -- -- -- --
Other Current Assets $341M $523M $381M $375M $535M
Total Current Assets $9.3B $14.8B $15.6B $14.1B $13.3B
 
Property Plant And Equipment $29.8B $30.3B $32.6B $35.3B $38.5B
Long-Term Investments $295M $232M $262M $207M $456M
Goodwill -- -- -- -- --
Other Intangibles $401M $412M $416M $422M $428M
Other Long-Term Assets $1.9B $1.8B $1.6B $1.9B $1.8B
Total Assets $42.1B $48B $51.1B $52.5B $54.8B
 
Accounts Payable $1.5B $2B $2.7B $2.5B $2.8B
Accrued Expenses $837M $857M $866M $540M $530M
Current Portion Of Long-Term Debt $34M $372M $1B $766M $41M
Current Portion Of Capital Lease Obligations $38M $38M $38M $84M $98M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $3.4B $5.9B $6.3B $5.8B $5.5B
 
Long-Term Debt $9.7B $9.1B $9.6B $8.7B $8.9B
Capital Leases -- -- -- -- --
Total Liabilities $23.5B $25B $26.2B $25.2B $26.1B
 
Common Stock $159M $160M $161M $162M $162M
Other Common Equity Adj -$583M -$388M -$320M -$274M -$314M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $8.5B $9B $9.3B $10.6B $11.2B
Total Equity $18.7B $23B $24.9B $27.3B $28.8B
 
Total Liabilities and Equity $42.1B $48B $51.1B $52.5B $54.8B
Cash and Short Terms $3.7B $8.1B $8.1B $4.8B $3.9B
Total Debt $9.7B $9.5B $10.6B $9.4B $8.9B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $865M $5.4B $4.5B $3.8B $4.4B
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $99M $98M $95M $109M $109M
Change in Accounts Receivable $132M -$472M $56M $166M $460M
Change in Inventories $42M -$618M -$573M -$873M -$638M
Cash From Operations $3B $7.7B $5.1B $5.3B $7.2B
 
Capital Expenditures $2B $2.1B $3.5B $4.8B $4.8B
Cash Acquisitions -- -$33M -- -- -$210M
Cash From Investing -$1.3B -$2B -$3.4B -$5B -$5B
 
Dividends Paid (Ex Special Dividend) -$73M -$331M -$866M -$863M -$865M
Special Dividend Paid
Long-Term Debt Issued $3.5B $1.2B $5.7B $1.8B $2.3B
Long-Term Debt Repaid -$3.7B -$1.5B -$4.5B -$3B -$2.8B
Repurchase of Common Stock -- -$488M -$1.3B -- -$59M
Other Financing Activities $87M -$471M -$748M -$632M -$1.9B
Cash From Financing -$128M -$1.3B -$1.6B -$2.7B -$3.3B
 
Beginning Cash (CF) $2.3B $3.9B $8.3B $8.4B $6.1B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.6B $4.4B $76M -$2.3B -$1.2B
Ending Cash (CF) $3.9B $8.3B $8.4B $6.1B $4.9B
 
Levered Free Cash Flow $1.1B $5.6B $1.7B $455M $2.4B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $858M $1.4B $977M $1B $721M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $39M $19M $20M $20M $15M
Change in Accounts Receivable -- -$254M -$400M -$384M $367M
Change in Inventories -$17M -$308M -$389M -$135M -$337M
Cash From Operations $1.3B $2.3B $1.1B $1.3B $1.4B
 
Capital Expenditures $388M $771M $1B $1.4B $1.2B
Cash Acquisitions -- -$150M -- -- --
Cash From Investing $169M -$733M -$1.1B -$1.4B -$1.2B
 
Dividends Paid (Ex Special Dividend) -- -$111M -$214M -$216M -$216M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $295M $568M $369M $595M $303M
Long-Term Debt Repaid -$619M -$789M -$449M -$586M -$1.1B
Repurchase of Common Stock -- -$488M -- -- --
Other Financing Activities $28M -$353M -$169M -$223M -$526M
Cash From Financing -$248M -$1.2B -$444M -$424M -$1.5B
 
Beginning Cash (CF) $2.7B $7.9B $8.8B $6.5B $6.2B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.2B $395M -$434M -$476M -$1.3B
Ending Cash (CF) $3.9B $8.3B $8.4B $6.1B $4.9B
 
Levered Free Cash Flow $939M $1.5B $22M -$42M $197M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $865M $5.4B $4.5B $3.8B $4.4B
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $99M $98M $95M $109M $109M
Change in Accounts Receivable $132M -$472M $56M $166M $460M
Change in Inventories $42M -$618M -$573M -$873M -$638M
Cash From Operations $3B $7.7B $5.1B $5.3B $7.2B
 
Capital Expenditures $2B $2.1B $3.5B $4.8B $4.8B
Cash Acquisitions -- -$33M -- -- -$210M
Cash From Investing -$1.3B -$2B -$3.4B -$5B -$5B
 
Dividends Paid (Ex Special Dividend) -$73M -$331M -$866M -$863M -$865M
Special Dividend Paid
Long-Term Debt Issued $3.5B $1.2B $5.7B $1.8B $2.3B
Long-Term Debt Repaid -$3.7B -$1.5B -$4.5B -$3B -$2.8B
Repurchase of Common Stock -- -$488M -$1.3B -- --
Other Financing Activities $87M -$471M -$748M -$632M -$1.9B
Cash From Financing -$128M -$1.3B -$1.6B -$2.7B -$3.3B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.6B $4.4B $76M -$2.3B -$1.2B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $1.1B $5.6B $1.7B $455M $2.4B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $5.4B $4.5B $3.8B $4.4B --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $98M $95M $109M $109M --
Change in Accounts Receivable -$472M $56M $166M $460M --
Change in Inventories -$618M -$573M -$873M -$638M --
Cash From Operations $7.7B $5.1B $5.3B $7.2B --
 
Capital Expenditures $2.1B $3.5B $4.8B $4.8B --
Cash Acquisitions -$33M -- -- -$210M --
Cash From Investing -$2B -$3.4B -$5B -$5B --
 
Dividends Paid (Ex Special Dividend) -$331M -$866M -$863M -$865M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.2B $5.7B $1.8B $2.3B --
Long-Term Debt Repaid -$1.5B -$4.5B -$3B -$2.8B --
Repurchase of Common Stock -$488M -$1.3B -- -$59M --
Other Financing Activities -$471M -$748M -$632M -$1.9B --
Cash From Financing -$1.3B -$1.6B -$2.7B -$3.3B --
 
Beginning Cash (CF) $23.2B $35.5B $29B $25B --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $4.4B $76M -$2.3B -$1.2B --
Ending Cash (CF) $27.6B $35.5B $26.6B $23.9B --
 
Levered Free Cash Flow $5.6B $1.7B $455M $2.4B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk Stock a Buy, Sell or Hold?
Is CyberArk Stock a Buy, Sell or Hold?

CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Is Palantir a Good Stock to Buy?
Is Palantir a Good Stock to Buy?

Palantir Technologies (PLTR) stock soared to its highest level in…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock